Charles Le Moyne

Charles-Le Moyne hospital in Canada selects RayStation to become their primary treatment planning system

Retrieved on: 
Friday, February 18, 2022
TCS, Patient, Cancer, CEO, Proton, Helium, HDR, Carbon, Electron, Nasdaq Stockholm, Radiation, RaySearch Laboratories, CICM, OAS, Photon, TPS, Ion, Karolinska Institute, Charles Le Moyne, OIS, Tomotherapy, Medical imaging

Further, the clinic has added new and advanced technology to the order, including multi-criteria optimization, dose tracking, adaptive planning and TomoTherapy planning.

Key Points: 
  • Further, the clinic has added new and advanced technology to the order, including multi-criteria optimization, dose tracking, adaptive planning and TomoTherapy planning.
  • Cancer treatment at Charles-Le Moyne hospital is provided by the team at Montrgie Integrated Cancer Center (CICM).
  • RaySearch markets the RayStation* treatment planning system (TPS) and the oncology information system (OIS) RayCare*.
  • RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.